Yeh, Li Ren .
HRN: 22-25-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 1.5GM (VIAL)
11/26/2022
12/02/2022
IVT
300mg
Q8
ATP, URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTIEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes